semaglutide fda approval history approves Ozempic® (semaglutide) as the only GLP-1 RA to reduce the risk of worsening kidney disease and cardiovascular death in adults with type 2 diabetes and chronic kidney disease FDA approves obesity drug that

Coverage Cuts and Mid-Treatment Disruptions Major insurers like CVS Caremark and Aetna, along with state programs such as Medi-Cal, are reducing or removing coverage for key GLP-1 medications, including Wegovy and Zepbound

Advanced question (high value): How does medication compare to other options like structured medical programs or surgery? Why this matters: Research shows that while medications can help, long-term outcomes often depend on ongoing support and strategy, not just the medication itself

Research indicates it can also boost hyaluronic acid, increasing skin hydration

Consistency is important for maintaining stable semaglutide blood levels

Store correctly: Once reconstituted, keep in the fridge (28 C)